ADIM
CVET

Alpha DNA Investment Management’s Covetrus, Inc. Common Stock CVET Stock Holding History

Alpha DNA Investment Management’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-27
Closed – – 727
2021
Q1 		$0 Hold
27
– – ﹤0.01% 815
2020
Q4 		$0 Buy
+27
New +$729 ﹤0.01% 639

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alpha DNA Investment Management's CVET Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Covetrus, Inc. Common Stock (CVET) in Q2 2021, closing a stake of 27 shares.

Alpha DNA Investment Management first reported a position in CVET in Q4 2020 and held it in 2 quarters. The position peaked at $0 in Q1 2021. 269 funds tracked by Wall St. Rank hold CVET as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Covetrus, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 27 Covetrus, Inc. Common Stock shares in Q2 2021.
  • Alpha DNA Investment Management first reported a position in Covetrus, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Covetrus, Inc. Common Stock position peaked at $0 in Q1 2021.
  • 269 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.